ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Hansoh Pharmaceutical Group Company Limited clinical trials

Part of Stellar Infinity Company Ltd., which holds 64.41% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 190 studies whose lead sponsor is Hansoh Pharmaceutical Group Company Limited or one of 3 companies grouped under it. 117 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 19, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare Hansoh Pharmaceutical Group with Eli Lilly and BeOne Medicines →

Pipeline: 42 programs

Each counted once: 40 with a study Hansoh Pharmaceutical Group Company Limited leads registered in the last two years, 2 more from Hansoh Pharmaceutical Group Company Limited's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 of 13 with the most live studies.

Program
risvutatug rezetecanPhase 3 · Hansoh Pharmaceutical Group Company Limited: Phase 3 · 17 live · Small Cell Lung Carcinoma · primary completion Dec 2026☆ Track
HS-10504Phase 3 · Hansoh Pharmaceutical Group Company Limited: Phase 3 · 7 live · Carcinoma, Non-Small-Cell Lung · primary completion Nov 2026☆ Track
HS-10506Phase 3 · Hansoh Pharmaceutical Group Company Limited: Phase 3 · 6 live · Sleep Initiation and Maintenance Disorders · primary completion Jun 2028☆ Track
aumolertinibPhase 3 · 5 live · Carcinoma, Non-Small-Cell Lung☆ Track
mocertatug rezetecanPhase 3 · Hansoh Pharmaceutical Group Company Limited: Phase 3 · 5 live · Ovarian Neoplasms · primary completion Mar 2027☆ Track

8 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Hansoh Pharmaceutical Group Company Limited’s own registered studies; “Hansoh Pharmaceutical Group Company Limited says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

3 of Hansoh Pharmaceutical Group’s programs have a dated deal behind them: 3 licensed out. Each from the companies’ own releases and filings, linked; the registry does not record them.

Licensed out 3

What it is testing

The drugs Hansoh Pharmaceutical Group Company Limited’s studies test, most open studies first — 40 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 40; every drug is on its own page, and each page lists its sponsors.

Coming up

28 of Hansoh Pharmaceutical Group Company Limited’s studies under way reach primary completion within a year, 5 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 7D
  3. 2J’27
  4. 2F
  5. 6M
  6. 2A
  7. 3M
  8. J
  9. 1J
  10. 1A
  11. 1S
  12. O
  13. 2N

The 12 nearest

Show 7 more

Add all 28 to your calendar (.ics) → With an account.

All 190 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now11762%Not yet recruiting 66 · Recruiting 51
  • Under way, not recruiting53%
  • Completed2714%
  • Stopped early11%
  • Status unknown or other4021%

Phase

Where

  • China138
  • United States3
  • Canada2
  • New Zealand1
  • Bulgaria1
  • Australia1

Over the years

  1. 11
  2. 12
  3. 13
  4. 14
  5. 15
  6. 16
  7. 17
  8. 18
  9. 19
  10. 20
  11. 21
  12. 22
  13. 23
  14. 24
  15. 25
  16. 3826

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hansoh Pharmaceutical Group Company Limited.

  • Jiangsu Hansoh Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    138 studies →
  • Hansoh BioMedical R&D Company
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    48 studies →
  • Shanghai Hansoh Biomedical Co., Ltd
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →

Focus areas

Conditions Hansoh Pharmaceutical Group Company Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 190. Browse all 190 →